The prognostic significance of low pretreatment anemia has previously been investigated in various cancers; low Hb is associated with poorer outcomes in many types of human cancer, particularly in HN cancers and gynecological tumors 26, 27, 28. This evidence concerns the gene GSTM1 and anemia.